These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18056431)

  • 81. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
    Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
    Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
    [No Abstract]   [Full Text] [Related]  

  • 82. Dynamic Behavior of p53 Driven by Delay and a Microrna-34a-Mediated Feedback Loop.
    Gao C; Liu H; Yan F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070036
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tumor suppressor p53 meets microRNAs.
    Feng Z; Zhang C; Wu R; Hu W
    J Mol Cell Biol; 2011 Feb; 3(1):44-50. PubMed ID: 21278451
    [TBL] [Abstract][Full Text] [Related]  

  • 84. MiR-1246: a new link of the p53 family with cancer and Down syndrome.
    Liao JM; Zhou X; Zhang Y; Lu H
    Cell Cycle; 2012 Jul; 11(14):2624-30. PubMed ID: 22751441
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Deciphering miRNAs associated with cellular stress response and apoptosis mechanisms regulated by p53 activity in patients with lower lip cancer.
    Bozgeyik I; Koparal M; Ege B; Bozgeyik E; Kurt MY; Ceylan O
    Pathol Res Pract; 2022 Aug; 236():153952. PubMed ID: 35724459
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Role of p53-miRNAs circuitry in immune surveillance and cancer development: A potential avenue for therapeutic intervention.
    Singh D; Khan MA; Siddique HR
    Semin Cell Dev Biol; 2022 Apr; 124():15-25. PubMed ID: 33875349
    [TBL] [Abstract][Full Text] [Related]  

  • 87. p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.
    Brosh R; Shalgi R; Liran A; Landan G; Korotayev K; Nguyen GH; Enerly E; Johnsen H; Buganim Y; Solomon H; Goldstein I; Madar S; Goldfinger N; Børresen-Dale AL; Ginsberg D; Harris CC; Pilpel Y; Oren M; Rotter V
    Mol Syst Biol; 2008; 4():229. PubMed ID: 19034270
    [TBL] [Abstract][Full Text] [Related]  

  • 88. miR-34: from bench to bedside.
    Agostini M; Knight RA
    Oncotarget; 2014 Feb; 5(4):872-81. PubMed ID: 24657911
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.
    Otsuka K; Ochiya T
    Biomed Res Int; 2014; 2014():749724. PubMed ID: 25302307
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Emerging role and function of miR-198 in human health and diseases.
    Kaushik P; Kumar A
    Pathol Res Pract; 2022 Jan; 229():153741. PubMed ID: 34952425
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53.
    Ugalde AP; Ramsay AJ; de la Rosa J; Varela I; Mariño G; Cadiñanos J; Lu J; Freije JM; López-Otín C
    EMBO J; 2011 Jun; 30(11):2219-32. PubMed ID: 21522133
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The guardian's choice: how p53 enables context-specific decision-making in individual cells.
    Friedel L; Loewer A
    FEBS J; 2022 Jan; 289(1):40-52. PubMed ID: 33590949
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MicroRNAs in mutagenesis, genomic instability, and DNA repair.
    Landau DA; Slack FJ
    Semin Oncol; 2011 Dec; 38(6):743-51. PubMed ID: 22082760
    [TBL] [Abstract][Full Text] [Related]  

  • 94. HypoxamiRs and cancer: from biology to targeted therapy.
    Gee HE; Ivan C; Calin GA; Ivan M
    Antioxid Redox Signal; 2014 Sep; 21(8):1220-38. PubMed ID: 24111776
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The microRNA and p53 families join forces against cancer.
    Barlev NA; Sayan BS; Candi E; Okorokov AL
    Cell Death Differ; 2010 Feb; 17(2):373-5. PubMed ID: 20062068
    [No Abstract]   [Full Text] [Related]  

  • 96. MicroRNA functions in stress responses.
    Leung AK; Sharp PA
    Mol Cell; 2010 Oct; 40(2):205-15. PubMed ID: 20965416
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Induction of p53-inducible microRNA miR-34 by gamma radiation and bleomycin are different.
    Mert U; Ozgür E; Tiryakioglu D; Dalay N; Gezer U
    Front Genet; 2012; 3():220. PubMed ID: 23091481
    [TBL] [Abstract][Full Text] [Related]  

  • 98. MicroRNAs and the cell cycle.
    Bueno MJ; Malumbres M
    Biochim Biophys Acta; 2011 May; 1812(5):592-601. PubMed ID: 21315819
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Synthetic miR-34a against solid tumours: a predictable failure.
    Mockly S; Seitz H
    Br J Cancer; 2023 Feb; 128(3):478-480. PubMed ID: 36550206
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reply: The Complex miRNAs-p53 Signaling Network in Cardiovascular Disease.
    Barwari T; Joshi A; Mayr M
    J Am Coll Cardiol; 2017 Apr; 69(16):2100. PubMed ID: 28427587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.